0
     

Report Added
Report already added
Analgesics in Peru

Analgesics in Peru

Adult acetaminophen is the largest category in analgesics and witnessed the most significant decline in 2022 as pandemic conditions subsided and Peruvian lifestyles returned to normality. As the most frequently consumed product to treat pain caused by COVID-19, current value sales surged in 2020, supported by government campaigns advocating the use of acetaminophen to treat COVID-19 and post-vaccine effects. Whilst current value sales remain above pre-pandemic levels, per capita consumption is e...

Euromonitor International's Analgesics in Peru report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Analgesics in Peru

List Of Contents And Tables

ANALGESICS IN PERU
KEY DATA FINDINGS
2022 DEVELOPMENTS
Adult acetaminophen sees decline as demand subsides post-pandemic
Product stockpiling has become common practice among consumers
GlaxoSmithKline (GSK) maintains leadership in the category
PROSPECTS AND OPPORTUNITIES
Generic analgesics to outpace other products in value sales growth
Laboratories promote advantages of ibuprofen to help recover sales
Aspirin faces lowest projected growth rates
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2017-2022
Table 2 Sales of Analgesics by Category: % Value Growth 2017-2022
Table 3 NBO Company Shares of Analgesics: % Value 2018-2022
Table 4 LBN Brand Shares of Analgesics: % Value 2019-2022
Table 5 Forecast Sales of Analgesics by Category: Value 2022-2027
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN PERU
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources

Report Title: Analgesics in Peru


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW